Your browser doesn't support javascript.
loading
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.
Tateai, Yoshikazu; Kawakami, Kazuyoshi; Teramae, Minori; Fukuda, Naoki; Yokokawa, Takashi; Kobayashi, Kazuo; Shibata, Naoki; Suzuki, Wataru; Shimizu, Hisanori; Takahashi, Shunji; Ozaka, Masato; Sasahira, Naoki; Hori, Satoko; Yamaguchi, Masakazu.
Afiliação
  • Tateai Y; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawakami K; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Teramae M; Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
  • Fukuda N; Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yokokawa T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kobayashi K; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Shibata N; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Suzuki W; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Shimizu H; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahashi S; Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ozaka M; Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sasahira N; Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hori S; Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
  • Yamaguchi M; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
PLoS One ; 18(11): e0294320, 2023.
Article em En | MEDLINE | ID: mdl-37972015

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Glândula Tireoide / Carcinoma Hepatocelular / Hipertensão / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Glândula Tireoide / Carcinoma Hepatocelular / Hipertensão / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article